查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421749

眼科藥品市場、份額、規模、趨勢、產業分析報告：依藥物類別、疾病、給藥途徑、產品類型、劑型、地區、細分市場預測，2023-2032

Ophthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球眼科藥品市場規模預計將達到735.7億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

眼科治療在白內障、青光眼、糖尿病視網膜病變、近視脈絡膜等多種眼部疾病的治療中發揮重要作用。 特別是，根據世界衛生組織（WHO）的數據，青光眼是全球第二大失明原因。 市面上提供多種眼科藥物，包括頭孢唑林、慶大霉素、EDTA 和貝伐珠單抗。 此外，加強醫療基礎設施、旨在提高全球健康意識的政府措施以及增加開發先進藥物的投資等因素也支持市場成長預期。

由於全球老年人口增加、已開發國家和新興國家青光眼患者數量增加以及眼部相關疾病的醫療保健支出增加等因素，市場收入份額預計將在預測期內擴大。

眼科藥物市場受到 COVID-19 大流行的負面影響。 例如，根據 2021 年 11 月《臨床眼科雜誌》報道，對大流行前和大流行後數據的分析發現，眼保健的各個方面均顯著下降。 疫情前與疫情後相比，視野檢查減少了93.84%，就診減少了92.52%，藥物治療減少了19.63%，手術減少了72.74%。 這些數據表明，在大流行期間，青光眼和其他眼部疾病的治療量顯著減少。 然而，隨著 COVID-19 疫苗的廣泛使用以及 COVID-19 病例數的持續下降，預計市場將會復甦。

此外，國家醫學圖書館 2021 年 6 月發表的一項研究強調了冠狀動脈疾病 (CAD) 對全球健康的重大影響。 據估計，僅 CAD 每年就會導致約 61 萬人死亡，佔死亡人數的四分之一，使其成為美國的主要原因。 隨著 CAD 盛行率的增加，對有效眼科藥物設備的需求不斷增長，以滿足這一緊迫的醫療需求。 因此，預計這一因素將在預測期內推動眼科藥物的需求。

眼科藥品市場報告重點

2022年，抗發炎領域佔據市場主導地位，佔據最大的銷售份額。 這是由於尋求眼部過敏和發炎治療的患者數量增加。 同時，抗VEGF領域預計在預測期內將呈現顯著的複合年增長率。 這一增長是由視網膜疾病盛行率上升推動的，包括糖尿病視網膜病變和老年黃斑部病變等疾病。 此外，這些疾病在人群中不斷增加的診斷率正在推動各個地區對抗 VEGF 治療的需求。

在整個預測期內，半固體細分市場佔據著市場份額。 該細分市場預計將實現更高的複合年增長率（CAGR），主要是由於批准和產品發布的增加。 這些批准包括多種產品，包括軟膏、懸浮液和凝膠。 藥膏的使用越來越多，特別是在治療發炎性疾病、感染和乾眼症方面，由於其療效的提高，使其越來越受歡迎。 此外，主要行業進入者為獲得批准和推出更廣泛的產品而加大力度，進一步推動了該細分市場的成長。

2022年，北美佔據最大市場榜首。 這一優勢得益於該地區眼病的高盛行率以及公眾對這些疾病的認識不斷提高。 此外，該行業主要參與者的持續研發努力預計將有助於該地區的進一步成長。 作為額外的好處，北美是Pfizer, Alcon, Bausch & Lomb等大公司的所在地，進一步增強了其市場地位。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球眼科藥物市場洞察

  • 眼藥水 - 產業快照
  • 眼科藥物市場動態
    • 推動者和機會
      • 由於臨床試驗和候選藥物的增加，對創新藥物和治療方法的需求不斷增加。
      • 隱形眼鏡的使用範圍擴大
    • 抑制因素和挑戰
      • 市場收入成長可能會因專利過期藥物或面臨審批延遲的藥物的供應而受到阻礙
  • 杵分析
  • 眼科製藥業的趨勢
  • COVID-19 感染的影響分析

第 5 章全球眼科藥物市場（依藥物類別）

  • 主要調查結果
  • 簡介
  • 抗 VEGF 劑
  • 抗青光眼
  • 抗發炎
  • 抗過敏
  • 其他

第 6 章全球眼科藥物市場（按疾病）

  • 主要調查結果
  • 簡介
  • 青光眼
  • 乾眼症
  • 視網膜疾病
  • 眼睛過敏
  • 眼部感染
  • 其他

第七章全球眼科藥物市場（依給藥途徑）

  • 主要調查結果
  • 簡介
  • 系統性
  • 本地
  • 局部眼科
  • 結膜下
  • 玻璃體內
  • 視網膜疾病
  • 球後
  • 前房內

第 8 章全球眼科藥品市場（依產品類型）

  • 主要調查結果
  • 簡介
  • 非處方藥
  • 處方藥

第9章全球眼科藥物市場，按劑型

  • 主要調查結果
  • 簡介
  • 半固體
  • 液體
  • 固體

第10章全球眼科藥物區域市場

  • 主要調查結果
  • 簡介
    • 2019-2032 年眼科藥物市場評估（按地區）
  • 眼科藥品市場 - 北美
    • 北美：2019-2032 年眼科藥物市場（依藥物類別）
    • 北美：眼科藥品市場（依產品類型），2019-2032 年
    • 北美：眼科藥品市場，依疾病分類，2019-2032 年
    • 北美：2019-2032 年眼科藥物市場（依給藥途徑）
    • 北美：2019-2032 年眼科藥品市場（按劑型）
    • 眼科藥品市場 - 美國
    • 眼科藥品市場 - 加拿大
  • 眼科藥品市場 - 歐洲
    • 歐洲：2019-2032 年眼科藥物市場（依藥物類別）
    • 歐洲：眼科藥品市場（依產品類型），2019-2032 年
    • 歐洲：眼科藥品市場，依疾病分類，2019-2032 年
    • 歐洲：2019-2032 年眼科藥物市場（依給藥途徑）
    • 歐洲：2019-2032 年眼科藥品市場（按劑型）
    • 眼科藥品市場 - 英國
    • 眼科藥品市場 - 法國
    • 眼科藥品市場 - 德國
    • 眼科藥品市場 - 義大利
    • 眼科藥品市場 - 西班牙
    • 眼科藥品市場 - 荷蘭
    • 眼科藥品市場 - 俄羅斯
  • 眼科藥品市場 - 亞太地區
    • 亞太地區：2019-2032 年眼科藥物市場（依藥物類別）
    • 亞太地區：眼科藥品市場（依產品類型），2019-2032 年
    • 亞太地區：眼科藥品市場，依疾病分類，2019-2032 年
    • 亞太地區：2019-2032 年眼科藥物市場（依給藥途徑）
    • 亞太地區：2019-2032 年眼科藥品市場（按劑型）
    • 中國眼科藥品市場
    • 眼科藥品市場 - 印度
    • 日本眼科藥品市場
    • 眼科藥品市場 - 馬來西亞
    • 印尼眼科藥品市場
    • 韓國眼科藥品市場
  • 眼科藥品市場 - 中東和非洲
    • 中東和非洲：2019-2032 年眼科藥物市場（依藥物類別）
    • 中東和非洲：2019-2032 年眼科藥品市場（依產品類型）
    • 中東和非洲：眼科藥品市場，依疾病分類，2019-2032 年
    • 中東和非洲：2019-2032 年眼科藥物市場（依給藥途徑）
    • 中東和非洲：2019-2032 年眼科藥品市場（按劑型）
    • 眼科藥品市場 - 沙烏地阿拉伯
    • 眼科藥品市場 - 阿拉伯聯合大公國
    • 眼科藥品市場 - 以色列
    • 眼科藥品市場 - 南非
  • 眼科藥品市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年眼科藥物市場（依藥物類別）
    • 拉丁美洲：眼科藥品市場（依產品類型），2019-2032 年
    • 拉丁美洲：眼科藥品市場，依疾病分類，2019-2032 年
    • 拉丁美洲：2019-2032 年眼科藥物市場（依給藥途徑）
    • 拉丁美洲：2019-2032 年眼科藥品市場（按劑型）
    • 眼科藥品市場 - 墨西哥
    • 眼科藥品市場 - 巴西
    • 眼科藥品市場 - 阿根廷

第十一章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十二章公司簡介

  • Alcon
  • Allergan（AbbVie Inc）
  • Bausch Health Companies Inc.
  • Bayer AG
  • Coherus Biosciences, Inc.
  • Genentech, Inc.（F. Hoffmann-La Roche Ltd）
  • Merck & Co., Inc
  • Nicox
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc
Product Code: PM4073

The global ophthalmic drug market size is expected to reach USD 73.57 billion by 2032, according to a new study by Polaris Market Research. The report "Opthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Anti-VEGF Agents, Anti-glaucoma, Anti-inflammatory, Antiallergy, Others); By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Ophthalmic drugs play a crucial role in the treatment of a range of eye diseases, including cataracts, glaucoma, diabetic retinopathy, myopic choroidal, and others. Notably, glaucoma, according to the World Health Organization (WHO), stands as the second leading cause of blindness worldwide. The market offers a variety of ophthalmology medications, such as cefazolin, gentamicin, EDTA, bevacizumab, and more. Furthermore, the anticipation of market growth is bolstered by factors such as enhanced healthcare infrastructure, government initiatives aimed at raising global health awareness, and increased investments in the development of advanced drug types.

The market revenue share is expected to grow during the forecast period due to factors like the increasing global elderly population, a rising number of glaucoma patients in both developed and developing countries, and higher healthcare spending on eye-related diseases.

The ophthalmic drugs market experienced adverse effects due to the COVID-19 pandemic. For instance, as reported in the Clinical Ophthalmology Journal in November 2021, an analysis of data from pre-pandemic and post-pandemic periods revealed a substantial decline in various aspects of eye care. Visual field checkups, clinical visits, medication releases, and surgical procedures saw reductions of 93.84%, 92.52%, 19.63%, and 72.74% when comparing the pre-pandemic and post-pandemic times. This data indicates a significant decrease in the treatment of glaucoma and other ophthalmic disorders during the pandemic. However, the market is expected to rebound as COVID-19 vaccines become widely available and the number of COVID-19 cases continues to decline.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective Opthalmic Drug devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for Opthalmic Drugs throughout the forecast period.

Opthalmic Drug Market Report Highlights

In 2022, the Anti-inflammatory segment dominated the market, capturing the largest share of revenue. This can be attributed to the increasing number of patients seeking treatment for ocular allergies and inflammation. Concurrently, the Anti-VEGF segment is expected to show a significant CAGR over the forecast period. This growth is propelled by the escalating prevalence of retinal disorders, including conditions like diabetic retinopathy and age-related macular degeneration, among others. Furthermore, the rising rate of diagnosis for these conditions within the population is fueling the demand for anti-VEGF therapy across various regions.

The Semisolid segment dominated the market share throughout the forecast period. This segment is anticipated to achieve a higher Compound Annual Growth Rate (CAGR), mainly due to the increasing number of approvals and product launches. These approvals encompass a range of products, including ointments, suspensions, gels, and others. The growing utilization of ointments, particularly in the treatment of inflammatory conditions, infections, and dry eye, has contributed to their rising popularity due to their enhanced effectiveness. Furthermore, the segment's growth is further propelled by the intensified efforts of key industry players to secure approvals and introduce a wider array of products.

In 2022, North America held the top position as the largest market. This dominance is influenced by a higher prevalence of eye diseases in the region and an increasing awareness of these conditions among the population. Moreover, the continuous research and development endeavors by key industry players are anticipated to contribute to the further growth of the region. Additionally, North America benefits from the presence of major players such as Pfizer Inc., Alcon, and Bausch and Lomb, which further bolster its market position.

The global key market players include: es, Inc., Genentech, Inc. (F. Hoffmann-La Roche Ltd), Merck & Co., Inc., Nicox, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc.

Polaris Market Research has segmented the Opthalmic Drug market report based on disease, drug class, route of administration, dosage form, product type, and region:

Opthalmic Drug, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

  • Glaucoma
  • Dry Eye
  • Retinal Disorders
  • Eye Allergy
  • Eye Infection
  • Others

Opthalmic Drug, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

  • Anti-VEGF Agents
  • Anti-glaucoma
  • Anti-inflammatory
  • Steroidal drugs
  • Non-steroidal drugs
  • Antiallergy
  • Others

Opthalmic Drug, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Systemic
  • Topical
  • Local Ocular
  • Subconjunctival
  • Intravitreal
  • Retinal Disorders
  • Retrobulbar
  • Intracameral

Opthalmic Drug, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

  • OTC Drugs
  • Prescription Drugs

Opthalmic Drug, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Semisolid
  • Liquid
  • Solid

Opthalmic Drug, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Ophthalmic Drug Market Insights

  • 4.1. Ophthalmic Drug - Industry Snapshot
  • 4.2. Ophthalmic Drug Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Propelled by increasing clinical trials and pipeline candidates, demand for innovative drugs and therapies is on the rise
      • 4.2.1.2. Growing utilization of contact lenses
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The growth in market revenue is likely to be hampered by the availability of drugs without patents and those facing delayed approval
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Ophthalmic Drug Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Ophthalmic Drug Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • 5.3. Anti-VEGF Agents
    • 5.3.1. Global Ophthalmic Drug Market, by Anti-VEGF Agents, by Region, 2019-2032 (USD Billion)
  • 5.4. Anti-glaucoma
    • 5.4.1. Global Ophthalmic Drug Market, by Anti-glaucoma, by Region, 2019-2032 (USD Billion)
  • 5.5. Anti-inflammatory
    • 5.5.1. Global Ophthalmic Drug Market, by Anti-inflammatory, by Region, 2019-2032 (USD Billion)
    • 5.5.2. Steroidal drugs
      • 5.5.2.1. Global Ophthalmic Drug Market, by Steroidal drugs, by Region, 2019-2032 (USD Billion)
    • 5.5.3. Non-steroidal drugs
      • 5.5.3.1. Global Ophthalmic Drug Market, by Non-steroidal drugs, by Region, 2019-2032 (USD Billion)
  • 5.6. Antiallergy
    • 5.6.1. Global Ophthalmic Drug Market, by Antiallergy, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Ophthalmic Drug Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Ophthalmic Drug Market, by Disease

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • 6.3. Glaucoma
    • 6.3.1. Global Ophthalmic Drug Market, by Glaucoma, by Region, 2019-2032 (USD Billion)
  • 6.4. Dry Eye
    • 6.4.1. Global Ophthalmic Drug Market, by Dry Eye, by Region, 2019-2032 (USD Billion)
  • 6.5. Retinal Disorders
    • 6.5.1. Global Ophthalmic Drug Market, by Retinal Disorders, by Region, 2019-2032 (USD Billion)
  • 6.6. Eye Allergy
    • 6.6.1. Global Ophthalmic Drug Market, by Eye Allergy, by Region, 2019-2032 (USD Billion)
  • 6.7. Eye Infection
    • 6.7.1. Global Ophthalmic Drug Market, by Eye Infection, by Region, 2019-2032 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Ophthalmic Drug Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Ophthalmic Drug Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • 7.3. Systemic
    • 7.3.1. Global Ophthalmic Drug Market, by Systemic, by Region, 2019-2032 (USD Billion)
  • 7.4. Topical
    • 7.4.1. Global Ophthalmic Drug Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 7.5. Local Ocular
    • 7.5.1. Global Ophthalmic Drug Market, by Local Ocular, by Region, 2019-2032 (USD Billion)
  • 7.6. Subconjunctival
    • 7.6.1. Global Ophthalmic Drug Market, by Subconjunctival, by Region, 2019-2032 (USD Billion)
  • 7.7. Intravitreal
    • 7.7.1. Global Ophthalmic Drug Market, by Intravitreal, by Region, 2019-2032 (USD Billion)
  • 7.8. Retinal Disorders
    • 7.8.1. Global Ophthalmic Drug Market, by Retinal Disorders, by Region, 2019-2032 (USD Billion)
  • 7.9. Retrobulbar
    • 7.9.1. Global Ophthalmic Drug Market, by Retrobulbar, by Region, 2019-2032 (USD Billion)
  • 7.10. Intracameral
    • 7.10.1. Global Ophthalmic Drug Market, by Intracameral, by Region, 2019-2032 (USD Billion)

8. Global Ophthalmic Drug Market, by Product Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • 8.3. OTC Drugs
    • 8.3.1. Global Ophthalmic Drug Market, by OTC Drugs, by Region, 2019-2032 (USD Billion)
  • 8.4. Prescription Drugs
    • 8.4.1. Global Ophthalmic Drug Market, by Prescription Drugs, by Region, 2019-2032 (USD Billion)

9. Global Ophthalmic Drug Market, by Dosage Form

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 9.3. Semisolid
    • 9.3.1. Global Ophthalmic Drug Market, by Semisolid, by Region, 2019-2032 (USD Billion)
  • 9.4. Liquid
    • 9.4.1. Global Ophthalmic Drug Market, by Liquid, by Region, 2019-2032 (USD Billion)
  • 9.5. Solid
    • 9.5.1. Global Ophthalmic Drug Market, by Solid, by Region, 2019-2032 (USD Billion)

10. Global Ophthalmic Drug Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Ophthalmic Drug Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Ophthalmic Drug Market - North America
    • 10.3.1. North America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.3.2. North America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.3.3. North America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.3.4. North America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.5. North America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.3.6. Ophthalmic Drug Market - U.S.
      • 10.3.6.1. U.S.: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.3.7. Ophthalmic Drug Market - Canada
      • 10.3.7.1. Canada: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.4. Ophthalmic Drug Market - Europe
    • 10.4.1. Europe: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.6. Ophthalmic Drug Market - UK
      • 10.4.6.1. UK: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.7. Ophthalmic Drug Market - France
      • 10.4.7.1. France: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.8. Ophthalmic Drug Market - Germany
      • 10.4.8.1. Germany: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.9. Ophthalmic Drug Market - Italy
      • 10.4.9.1. Italy: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.10. Ophthalmic Drug Market - Spain
      • 10.4.10.1. Spain: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.11. Ophthalmic Drug Market - Netherlands
      • 10.4.11.1. Netherlands: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.12. Ophthalmic Drug Market - Russia
      • 10.4.12.1. Russia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.5. Ophthalmic Drug Market - Asia Pacific
    • 10.5.1. Asia Pacific: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.6. Ophthalmic Drug Market - China
      • 10.5.6.1. China: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.7. Ophthalmic Drug Market - India
      • 10.5.7.1. India: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.8. Ophthalmic Drug Market - Japan
      • 10.5.8.1. Japan: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.9. Ophthalmic Drug Market - Malaysia
      • 10.5.9.1. Malaysia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.10. Ophthalmic Drug Market - Indonesia
      • 10.5.10.1. Indonesia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.11. Ophthalmic Drug Market - South Korea
      • 10.5.11.1. South Korea: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.6. Ophthalmic Drug Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.6. Ophthalmic Drug Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.7. Ophthalmic Drug Market - UAE
      • 10.6.7.1. UAE: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.8. Ophthalmic Drug Market - Israel
      • 10.6.8.1. Israel: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.9. Ophthalmic Drug Market - South Africa
      • 10.6.9.1. South Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.7. Ophthalmic Drug Market - Latin America
    • 10.7.1. Latin America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.7.6. Ophthalmic Drug Market - Mexico
      • 10.7.6.1. Mexico: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.7.7. Ophthalmic Drug Market - Brazil
      • 10.7.7.1. Brazil: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.7.8. Ophthalmic Drug Market - Argentina
      • 10.7.8.1. Argentina: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Alcon
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Allergan (AbbVie Inc)
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bausch Health Companies Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bayer AG
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Coherus Biosciences, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Merck & Co., Inc
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Nicox
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Novartis AG
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Pfizer Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Regeneron Pharmaceuticals Inc
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development

List of Tables

  • Table 1 Global Ophthalmic Drug Market, by Drug Class, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Ophthalmic Drug Market, by Disease, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Ophthalmic Drug Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Ophthalmic Drug Market, by Dosage Form, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Ophthalmic Drug Market, by Product Type, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 7 North America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 8 North America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 9 North America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 10 North America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 12 U.S.: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 13 U.S.: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 14 U.S.: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 15 U.S.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 17 Canada: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 18 Canada: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 Canada: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 20 Canada: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 21 Europe: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 22 Europe: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 23 Europe: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Europe: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 25 Europe: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 26 Germany: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 27 Germany: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 28 Germany: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 29 Germany: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 30 Germany: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 31 France: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 32 France: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 33 France: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 France: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 35 France: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 36 UK: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 37 UK: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 38 UK: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 39 UK: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 40 UK: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 41 Italy: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 42 Italy: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 43 Italy: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 44 Italy: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 45 Italy: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 51 Spain: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 52 Spain: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 53 Spain: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 54 Spain: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 55 Spain: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 56 Russia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 57 Russia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 58 Russia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 59 Russia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 60 Russia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 66 China: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 67 China: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 68 China: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 69 China: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 70 China: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 71 Japan: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 72 Japan: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 73 Japan: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 74 Japan: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 75 Japan: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 76 India: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 77 India: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 78 India: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 India: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 80 India: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 91 South Korea: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 92 South Korea: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 93 South Korea: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 94 South Korea: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 95 South Korea: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 96 Latin America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 97 Latin America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 98 Latin America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 99 Latin America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 100 Latin America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 101 Brazil: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 102 Brazil: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 103 Brazil: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 104 Brazil: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 105 Brazil: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 106 Mexico: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 107 Mexico: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 108 Mexico: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 109 Mexico: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 110 Mexico: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 111 Argentina: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 112 Argentina: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 113 Argentina: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 114 Argentina: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 115 Argentina: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 121 UAE: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 122 UAE: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 123 UAE: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 124 UAE: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 125 UAE: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 131 South Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 132 South Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 133 South Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 134 South Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 135 South Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 136 Israel: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 137 Israel: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 138 Israel: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 139 Israel: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 140 Israel: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Ophthalmic Drug Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Class
  • Figure 7. Global Ophthalmic Drug Market, by Drug Class, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Disease
  • Figure 9. Global Ophthalmic Drug Market, by Disease, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Ophthalmic Drug Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Dosage Form
  • Figure 13. Global Ophthalmic Drug Market, by Dosage Form, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Product Type
  • Figure 15. Global Ophthalmic Drug Market, by Product Type, 2021 & 2030 (USD Billion)